¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"central intermediate substance"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
intermediate trait
Áß°£¼ºÇâ(¼ÒÁú)
intermediate-acting insulin
Áß°£ÀÛ¿ëÀν¶¸°
reactive intermediate
¹ÝÀÀÁß°£¹°Áú
replicative intermediate
º¹Á¦Áß°£»ê¹°
antibacterial substance
Ç×±Õ¹°Áú
antifungal substance
Ç×Áø±Õ¹°Áú
carcinogenic substance
¹ß¾Ï¹°Áú
cortical substance
°ÑÁú, ÇÇÁú
crystalline substance
°áÁ¤¹°Áú
cement substance
Á¢ÇÕÁú, ½Ã¸àÆ®¹°Áú
chromophil substance
È£»ö¼Òü, »ö¼Òģȹ°Áú
depressor substance
°¨¾Ð¹°Áú
ferromagnetic substance
°ÀÚ¼º¹°Áú
gelatinous substance
Á©¶óƾ¹°Áú
gray substance
ȸ»öÁú, ȸ¹éÁú
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
2
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
toxic substance
µ¶¼º¹°Áú
substance withdrawal
¹°Áú±Ý´Ü
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
intermediate variable
Áß°£º¯¼ö
intermediate density lipoprotein
Á߹еµÁöÁú´Ü¹é
intermediate cell mass
Áß°£¼¼Æ÷µ¢ÀÌ
intermediate field magnetic resonance scanner
ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
reactive intermediate
¹ÝÀÀÁß°£¹°Áú
replicative intermediate
º¹Á¦Áß°£»ê¹°
posterior intermediate sulcus
µÚÁß°£°í¶û
central amaurosis
ÁßÃßÈæ¾Ï½Ã
central aphasia
ÁßÃß¾ð¾î»ó½ÇÁõ
central artery
Á߽ɵ¿¸Æ
central ataxia
ÁßÃßÁ¶È¿îµ¿ºÒ´É
central attachment
Á߽ɺÎÂø
central retinal artery
¸Á¸·Á߽ɵ¿¸Æ
central visual acuity
Á߽ɽ÷Â
central
Áß½É-, ÁßÃß-
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
glial cell of central nervous system
ÁßÃ߾Ʊ³¼¼Æ÷
gray central
Áß½Éȸ»öÁú(ñéãýüéßäòõ).
harversian canal central canal
Á߽ɰü
hearing loss, central
ÁßÃß¼º û·Â¼Ò½Ç, ÁßÃß¼º ³Ã»
posterolateral central arteries
µÚ°¡ÂÊÁ߽ɵ¿¸Æ
posteromedial central arteries
µÚ¾ÈÂÊÁ߽ɵ¿¸Æ
C-substance
C-¹°Áú.
EPS=£¾exophthalmos producing substance
¾È±¸µ¹ÃâÀ¯¹ß¹°Áú.
Goitrogenic substance
°©»ó¼±Á¾À¯¹ß¹°Áú(Ë£ßÒàÍðþë¯Û¡Úªòõ)
Inducer substance
À¯µµ¹°Áú(ë¯ÓôÚªòõ)
Inhibitor substance
¾ïÁ¦¹°Áú(åäð¤Úªòõ)
Kerry reducing substance test
Äɸ®È¯¿ø¹°Áú½ÃÇè
Mullerian inhibiting substance
¹°·¯°ü ¾ïÁ¦¹°Áú
P substance
P¹°Áú
SRS A : slow reacting substance A
¿¡½º¾Ë¿¡½º-¿¡ÀÌ.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
intermediate cervical septum
Áß°£¸ñ»çÀ̸·
intermediate cervical sympathetic ganglion
intermediate coat
Áß°£Ãþ(ñéÊàöµ).
intermediate coupling
Áß°£°áÇÕ.
intermediate crest ³ª crista sacralis intermedia
Áß°£ õ°ñ ¸ª.
intermediate crest ³ª crista sacralis intermedia
Áß°£Ãµ°ñ¸ª.
intermediate cuneiform bone
Áß°£½û±â»À
intermediate cuneiform bone ³ª os cuneiforme intermedium
Áß°£ ¼³»ó°ñ(ñéÊààÛßÒÍé).
intermediate cuneiform bone ³ª os cuneiforme intermedium
Áß°£¼³»ó°ñ.
intermediate deep temporal nerve
intermediate density lipoprotein =IDL ´ç´¢
Áß°£ºñÁßÁö(Áú)´Ü¹é(Áú).
intermediate dorsal cutaneous nerve
Áß°£¹ßµîÇǺνŰæ
intermediate fetal death
Áß±âžƻç.
intermediate field MR scanner
ÁßµîÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
intermediate filaments
Áß°£¼¼»ç(Áß°£Çü Çʶó¸àÆ®)(ñéÊàá¬Þê)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½